Matches in Wikidata for { <http://www.wikidata.org/entity/Q59334540> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q59334540 description "article scientifique publié en 2018" @default.
- Q59334540 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59334540 description "wetenschappelijk artikel" @default.
- Q59334540 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q59334540 name "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 name "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 type Item @default.
- Q59334540 label "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 label "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 prefLabel "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 prefLabel "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 P1433 Q59334540-00D1CE71-3A7D-4350-8B28-3B659782DD4B @default.
- Q59334540 P1476 Q59334540-347100E7-B251-4A31-82C9-51F043CF18E4 @default.
- Q59334540 P2093 Q59334540-1428EE68-68B9-4578-AEA3-9B29461EDA8E @default.
- Q59334540 P2093 Q59334540-2C965E38-E4DA-403E-A6B5-79C0FB42F53B @default.
- Q59334540 P2093 Q59334540-590C12A8-DCA8-4E2A-8C97-B1A3B91D95AA @default.
- Q59334540 P2093 Q59334540-76E5C834-44A6-4118-B88B-155A12E8B01B @default.
- Q59334540 P2093 Q59334540-816E746A-C478-4010-A818-1136F853041B @default.
- Q59334540 P2093 Q59334540-9BD52081-9D6C-406F-8395-C22ED925DAA5 @default.
- Q59334540 P2093 Q59334540-9CA000EE-CC3A-44F4-BE5C-D1E654AC86BA @default.
- Q59334540 P2093 Q59334540-DACF969C-657F-4A77-8641-097169354FDA @default.
- Q59334540 P2093 Q59334540-E517F49A-6CE5-4369-AA68-30D854DE9E46 @default.
- Q59334540 P2093 Q59334540-E59409F7-FA3B-4962-BCFF-F78B47D49170 @default.
- Q59334540 P275 Q59334540-6953f994-229d-4849-8248-35e2d9d1896f @default.
- Q59334540 P304 Q59334540-53E6E569-4B4B-4D97-BFC3-5BD6CEEB91A7 @default.
- Q59334540 P31 Q59334540-F3F6CEAF-C783-46BF-8854-33F8A2887C72 @default.
- Q59334540 P356 Q59334540-9E138D5C-B10A-4CA4-BF08-0FC9CAB75C3E @default.
- Q59334540 P433 Q59334540-6685C281-AD47-4238-81F2-0B79E4865D0A @default.
- Q59334540 P478 Q59334540-D4A07A6B-FF49-407C-85D6-4C98B9A1E405 @default.
- Q59334540 P50 Q59334540-5F442169-DB18-40CC-8833-DBF7D46065C3 @default.
- Q59334540 P577 Q59334540-921B3610-5A2C-4991-A8FB-0D1517A540C8 @default.
- Q59334540 P6216 Q59334540-0cde8b0f-94a6-4073-bd56-eb0ad7e344a6 @default.
- Q59334540 P921 Q59334540-435097C8-F088-426D-8D1D-7E8A35BA3E41 @default.
- Q59334540 P932 Q59334540-05817993-13D5-4D5F-A59A-593089EE07F9 @default.
- Q59334540 P356 OFY210.1614 @default.
- Q59334540 P1433 Q27725953 @default.
- Q59334540 P1476 "1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005" @default.
- Q59334540 P2093 "Bart Remmerie" @default.
- Q59334540 P2093 "Dymphy Huntjens" @default.
- Q59334540 P2093 "Eugenio Baraldi" @default.
- Q59334540 P2093 "Federico Martinon-Torres" @default.
- Q59334540 P2093 "Fernando Ferrero" @default.
- Q59334540 P2093 "Johan Vingerhoets" @default.
- Q59334540 P2093 "Katie McFadyen" @default.
- Q59334540 P2093 "Marita Stevens" @default.
- Q59334540 P2093 "Pablo Rojo Conejo" @default.
- Q59334540 P2093 "Sarah Rusch" @default.
- Q59334540 P275 Q24082749 @default.
- Q59334540 P304 "S566-S567" @default.
- Q59334540 P31 Q13442814 @default.
- Q59334540 P356 "10.1093/OFID/OFY210.1614" @default.
- Q59334540 P433 "suppl_1" @default.
- Q59334540 P478 "5" @default.
- Q59334540 P50 Q91222410 @default.
- Q59334540 P577 "2018-11-01T00:00:00Z" @default.
- Q59334540 P6216 Q50423863 @default.
- Q59334540 P921 Q424227 @default.
- Q59334540 P932 "6252897" @default.